Tata Industries picks up a stake in Indigene Pharmaceuticals

Tata Industries picks up a stake in Indigene Pharmaceuticals

Tata Industries Ltd has reportedly purchased a 26-30% stake in US-based Indigene Pharmaceuticals. Indigene is expanding fast and has operations in Boston, Europe and India.

The company focuses on developing and delivering molecular combination-based products for global prenoscription and consumer healthcare markets.

Ratan N Tata, chairman, TIL spoke on this new development: “The Tata Group has been actively seeking new opportunities in knowledge-based industries. Biotechnology and biopharmaceutical areas offer great potential in creating value and improving the quality of life for people around the world.”

Indigene is also said to be ready to launch four consumer healthcare products in large self-medication areas initially in the US. This would be further expanded to Indian and other international markets in the coming months.